Autolus Therapeutics Reports Q2 2026 Financial Results

What Happened

• On August 11, 2026 Autolus Therapeutics plc announced its financial results for the quarter ended June 30, 2026 and provided a corporate update. The company furnished a press release (Exhibit 99.1) and an updated corporate presentation (Exhibit 99.2) in connection with its August 11, 2026 conference call. The Form 8‑K was signed by CEO Christian Itin, Ph.D.

Key Details

• Filing date: August 11, 2026; quarter covered: ended June 30, 2026.
• Exhibit 99.1: Press release dated August 11, 2026 (financial results and update).
• Exhibit 99.2: Corporate presentation dated August 11, 2026 used on the company’s results conference call.
• Reported under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Why It Matters

• The furnished press release and slides are the primary sources for the company’s latest quarterly results, operational progress and any updates on programs or guidance; investors should review those exhibits and the conference call for details on revenue, expenses, cash runway and program milestones.
• This 8‑K does not report management changes or corporate transactions; it formally records the company’s public release of results and updated investor presentation.